| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mental Disorders | 379 | 2024 | 6699 | 22.410 |
Why?
|
| Military Personnel | 129 | 2024 | 1162 | 19.540 |
Why?
|
| Health Surveys | 288 | 2024 | 4050 | 14.460 |
Why?
|
| Suicide, Attempted | 110 | 2024 | 1224 | 13.930 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 152 | 2024 | 1973 | 11.980 |
Why?
|
| Suicidal Ideation | 89 | 2024 | 1262 | 9.150 |
Why?
|
| Stress Disorders, Post-Traumatic | 119 | 2024 | 4347 | 8.710 |
Why?
|
| Depressive Disorder, Major | 102 | 2024 | 4692 | 8.200 |
Why?
|
| Anxiety Disorders | 146 | 2024 | 2713 | 8.020 |
Why?
|
| Suicide | 64 | 2023 | 1495 | 7.090 |
Why?
|
| Mental Health Services | 75 | 2024 | 1671 | 6.890 |
Why?
|
| Life Change Events | 70 | 2021 | 942 | 6.570 |
Why?
|
| Students | 68 | 2024 | 1668 | 6.220 |
Why?
|
| Comorbidity | 262 | 2024 | 10450 | 6.210 |
Why?
|
| Prevalence | 326 | 2024 | 15404 | 6.200 |
Why?
|
| World Health Organization | 81 | 2023 | 1330 | 6.050 |
Why?
|
| Mood Disorders | 63 | 2024 | 1115 | 5.860 |
Why?
|
| Resilience, Psychological | 35 | 2023 | 699 | 4.900 |
Why?
|
| Mental Health | 82 | 2024 | 3074 | 4.590 |
Why?
|
| Interview, Psychological | 48 | 2024 | 817 | 4.590 |
Why?
|
| Age of Onset | 97 | 2023 | 3290 | 4.410 |
Why?
|
| Psychiatric Status Rating Scales | 108 | 2024 | 6050 | 4.130 |
Why?
|
| Adolescent | 486 | 2024 | 86713 | 4.060 |
Why?
|
| Substance-Related Disorders | 88 | 2023 | 4290 | 4.020 |
Why?
|
| Depressive Disorder | 96 | 2024 | 3759 | 3.860 |
Why?
|
| Cross-Cultural Comparison | 32 | 2019 | 650 | 3.850 |
Why?
|
| Adult | 723 | 2024 | 216658 | 3.710 |
Why?
|
| Absenteeism | 29 | 2013 | 251 | 3.700 |
Why?
|
| Phobic Disorders | 35 | 2023 | 439 | 3.630 |
Why?
|
| Cost of Illness | 37 | 2023 | 1873 | 3.520 |
Why?
|
| Alcoholism | 49 | 2024 | 1936 | 3.400 |
Why?
|
| Disasters | 17 | 2017 | 518 | 3.330 |
Why?
|
| Young Adult | 273 | 2024 | 57267 | 3.230 |
Why?
|
| Afghan Campaign 2001- | 26 | 2022 | 272 | 3.230 |
Why?
|
| Depression | 74 | 2024 | 7876 | 3.230 |
Why?
|
| Universities | 51 | 2024 | 970 | 3.190 |
Why?
|
| Violence | 22 | 2020 | 919 | 3.110 |
Why?
|
| Male | 753 | 2024 | 354311 | 3.040 |
Why?
|
| Humans | 1108 | 2024 | 752741 | 2.990 |
Why?
|
| Female | 781 | 2024 | 385090 | 2.950 |
Why?
|
| United States | 335 | 2024 | 70772 | 2.910 |
Why?
|
| Risk Assessment | 73 | 2023 | 23554 | 2.790 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 16 | 2024 | 1019 | 2.750 |
Why?
|
| Sex Offenses | 9 | 2022 | 360 | 2.650 |
Why?
|
| Developed Countries | 23 | 2021 | 442 | 2.640 |
Why?
|
| Chronic Disease | 48 | 2023 | 9223 | 2.410 |
Why?
|
| Middle Aged | 469 | 2024 | 216054 | 2.410 |
Why?
|
| Crime Victims | 10 | 2019 | 324 | 2.390 |
Why?
|
| Veterans | 10 | 2023 | 2554 | 2.270 |
Why?
|
| Risk Factors | 272 | 2024 | 73094 | 2.260 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 26 | 2021 | 3661 | 2.020 |
Why?
|
| Patient Acceptance of Health Care | 43 | 2024 | 3069 | 1.980 |
Why?
|
| Cross-Sectional Studies | 156 | 2023 | 25454 | 1.960 |
Why?
|
| Child of Impaired Parents | 14 | 2017 | 457 | 1.900 |
Why?
|
| Employment | 19 | 2017 | 1140 | 1.880 |
Why?
|
| Psychometrics | 36 | 2022 | 3014 | 1.870 |
Why?
|
| Socioeconomic Factors | 70 | 2020 | 7852 | 1.760 |
Why?
|
| Urban Population | 17 | 2018 | 2031 | 1.740 |
Why?
|
| Stress, Psychological | 43 | 2023 | 4316 | 1.680 |
Why?
|
| Mass Screening | 29 | 2022 | 5282 | 1.670 |
Why?
|
| Severity of Illness Index | 90 | 2024 | 15657 | 1.660 |
Why?
|
| Psychotherapy | 19 | 2023 | 1657 | 1.660 |
Why?
|
| Social Class | 24 | 2019 | 2005 | 1.640 |
Why?
|
| Affective Symptoms | 8 | 2017 | 409 | 1.620 |
Why?
|
| Self Report | 25 | 2023 | 3618 | 1.590 |
Why?
|
| Panic Disorder | 24 | 2021 | 617 | 1.550 |
Why?
|
| Disability Evaluation | 14 | 2021 | 1842 | 1.540 |
Why?
|
| Psychotic Disorders | 20 | 2024 | 3102 | 1.520 |
Why?
|
| Anxiety | 36 | 2024 | 4395 | 1.450 |
Why?
|
| Developing Countries | 24 | 2022 | 2847 | 1.420 |
Why?
|
| Child Abuse | 16 | 2023 | 1056 | 1.420 |
Why?
|
| Self-Injurious Behavior | 13 | 2024 | 469 | 1.410 |
Why?
|
| International Classification of Diseases | 13 | 2019 | 866 | 1.400 |
Why?
|
| Marriage | 17 | 2019 | 341 | 1.380 |
Why?
|
| Aged | 230 | 2024 | 165629 | 1.360 |
Why?
|
| Public Housing | 3 | 2016 | 146 | 1.360 |
Why?
|
| Saudi Arabia | 8 | 2024 | 210 | 1.340 |
Why?
|
| Residence Characteristics | 18 | 2023 | 2064 | 1.320 |
Why?
|
| Income | 25 | 2019 | 1921 | 1.310 |
Why?
|
| Accidents, Traffic | 10 | 2022 | 821 | 1.300 |
Why?
|
| Age Factors | 85 | 2020 | 18460 | 1.290 |
Why?
|
| Accidents, Occupational | 6 | 2014 | 249 | 1.290 |
Why?
|
| Health Care Surveys | 17 | 2018 | 2454 | 1.290 |
Why?
|
| Health Status | 28 | 2020 | 4077 | 1.280 |
Why?
|
| Disabled Persons | 11 | 2021 | 1229 | 1.270 |
Why?
|
| Adult Survivors of Child Abuse | 9 | 2023 | 277 | 1.260 |
Why?
|
| Longitudinal Studies | 58 | 2024 | 14219 | 1.260 |
Why?
|
| Efficiency | 10 | 2009 | 468 | 1.250 |
Why?
|
| Forecasting | 16 | 2020 | 2956 | 1.210 |
Why?
|
| Internationality | 18 | 2019 | 999 | 1.200 |
Why?
|
| Sex Factors | 82 | 2021 | 10469 | 1.190 |
Why?
|
| Epidemiologic Research Design | 9 | 2013 | 366 | 1.180 |
Why?
|
| Educational Status | 32 | 2020 | 2573 | 1.160 |
Why?
|
| Impulsive Behavior | 7 | 2023 | 323 | 1.160 |
Why?
|
| Marital Status | 11 | 2019 | 440 | 1.160 |
Why?
|
| Agoraphobia | 12 | 2019 | 179 | 1.140 |
Why?
|
| Alcohol-Related Disorders | 7 | 2020 | 235 | 1.140 |
Why?
|
| Interviews as Topic | 33 | 2021 | 2580 | 1.130 |
Why?
|
| Stress Disorders, Traumatic | 2 | 2019 | 53 | 1.120 |
Why?
|
| Tobacco Use Disorder | 13 | 2021 | 692 | 1.090 |
Why?
|
| Cyclonic Storms | 5 | 2011 | 120 | 1.080 |
Why?
|
| Patient Dropouts | 6 | 2020 | 418 | 1.080 |
Why?
|
| Activities of Daily Living | 17 | 2018 | 2457 | 1.080 |
Why?
|
| Adaptation, Psychological | 34 | 2020 | 2611 | 1.070 |
Why?
|
| Diseases in Twins | 32 | 2002 | 451 | 1.060 |
Why?
|
| Models, Psychological | 13 | 2019 | 813 | 1.040 |
Why?
|
| ROC Curve | 22 | 2023 | 3558 | 1.020 |
Why?
|
| Logistic Models | 57 | 2019 | 13441 | 1.020 |
Why?
|
| Psychopathology | 12 | 2023 | 418 | 1.010 |
Why?
|
| Family | 27 | 2013 | 3175 | 1.010 |
Why?
|
| Child Behavior Disorders | 9 | 2013 | 805 | 1.000 |
Why?
|
| Demography | 25 | 2021 | 1661 | 0.990 |
Why?
|
| Motor Vehicles | 8 | 2023 | 271 | 0.990 |
Why?
|
| Marijuana Abuse | 8 | 2018 | 404 | 0.970 |
Why?
|
| Poverty | 8 | 2018 | 2682 | 0.970 |
Why?
|
| Population Surveillance | 19 | 2018 | 2618 | 0.970 |
Why?
|
| Adolescent Behavior | 6 | 2020 | 1162 | 0.960 |
Why?
|
| Social Environment | 27 | 2010 | 1025 | 0.950 |
Why?
|
| Conduct Disorder | 5 | 2009 | 241 | 0.940 |
Why?
|
| Antidepressive Agents | 14 | 2023 | 2863 | 0.930 |
Why?
|
| Data Collection | 30 | 2012 | 3350 | 0.930 |
Why?
|
| Sampling Studies | 23 | 2009 | 623 | 0.920 |
Why?
|
| Bipolar Disorder | 24 | 2021 | 5069 | 0.910 |
Why?
|
| Models, Statistical | 20 | 2021 | 5107 | 0.900 |
Why?
|
| Complementary Therapies | 12 | 2017 | 485 | 0.900 |
Why?
|
| Age Distribution | 25 | 2019 | 2905 | 0.890 |
Why?
|
| Fear | 11 | 2023 | 1452 | 0.880 |
Why?
|
| China | 16 | 2017 | 2306 | 0.870 |
Why?
|
| Health Services Needs and Demand | 14 | 2019 | 1417 | 0.860 |
Why?
|
| Firearms | 3 | 2021 | 614 | 0.860 |
Why?
|
| Lung Diseases, Obstructive | 10 | 2001 | 313 | 0.860 |
Why?
|
| Health Services Accessibility | 20 | 2022 | 5222 | 0.840 |
Why?
|
| Attitude to Health | 11 | 2013 | 2058 | 0.830 |
Why?
|
| Occupational Diseases | 7 | 2021 | 1471 | 0.830 |
Why?
|
| Domestic Violence | 5 | 2017 | 176 | 0.830 |
Why?
|
| Smoking | 26 | 2020 | 9030 | 0.820 |
Why?
|
| Anger | 6 | 2021 | 402 | 0.820 |
Why?
|
| Needs Assessment | 9 | 2015 | 1151 | 0.820 |
Why?
|
| Internal-External Control | 13 | 2015 | 364 | 0.810 |
Why?
|
| Anxiety, Separation | 3 | 2015 | 86 | 0.800 |
Why?
|
| Ownership | 2 | 2021 | 337 | 0.790 |
Why?
|
| Odds Ratio | 45 | 2018 | 9863 | 0.790 |
Why?
|
| Workplace | 9 | 2009 | 844 | 0.790 |
Why?
|
| Wounds and Injuries | 11 | 2021 | 2436 | 0.790 |
Why?
|
| Risk | 32 | 2023 | 9683 | 0.780 |
Why?
|
| Reproducibility of Results | 56 | 2022 | 20026 | 0.780 |
Why?
|
| Alcohol Drinking | 17 | 2023 | 3998 | 0.760 |
Why?
|
| Retrospective Studies | 95 | 2024 | 78758 | 0.760 |
Why?
|
| Time Factors | 61 | 2020 | 40195 | 0.760 |
Why?
|
| Employee Performance Appraisal | 5 | 2011 | 88 | 0.750 |
Why?
|
| Obsessive-Compulsive Disorder | 4 | 2024 | 1455 | 0.730 |
Why?
|
| Lung Abscess | 1 | 2020 | 42 | 0.730 |
Why?
|
| Behavioral Symptoms | 3 | 2020 | 180 | 0.730 |
Why?
|
| Health Care Costs | 14 | 2023 | 3217 | 0.730 |
Why?
|
| Internet | 9 | 2024 | 3074 | 0.730 |
Why?
|
| Models, Theoretical | 4 | 2021 | 3586 | 0.720 |
Why?
|
| Work | 5 | 2006 | 194 | 0.720 |
Why?
|
| Spain | 16 | 2024 | 467 | 0.720 |
Why?
|
| Epidemiologic Methods | 18 | 2012 | 1366 | 0.710 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 10 | 2016 | 298 | 0.710 |
Why?
|
| Irritable Mood | 2 | 2013 | 183 | 0.710 |
Why?
|
| Occupational Health | 7 | 2008 | 807 | 0.710 |
Why?
|
| Role | 4 | 2009 | 176 | 0.700 |
Why?
|
| Prospective Studies | 64 | 2024 | 53863 | 0.700 |
Why?
|
| Genome-Wide Association Study | 25 | 2024 | 12432 | 0.690 |
Why?
|
| Child | 93 | 2023 | 78594 | 0.690 |
Why?
|
| Divorce | 5 | 2011 | 79 | 0.680 |
Why?
|
| Decision Support Systems, Clinical | 3 | 2019 | 1185 | 0.680 |
Why?
|
| Europe | 23 | 2017 | 3359 | 0.680 |
Why?
|
| Employer Health Costs | 4 | 2008 | 21 | 0.680 |
Why?
|
| Social Adjustment | 7 | 2017 | 633 | 0.670 |
Why?
|
| Regression Analysis | 28 | 2016 | 6458 | 0.670 |
Why?
|
| Epidemiologic Studies | 8 | 2018 | 679 | 0.660 |
Why?
|
| Self-Assessment | 6 | 2017 | 389 | 0.650 |
Why?
|
| Family Health | 8 | 2012 | 1279 | 0.650 |
Why?
|
| Argentina | 8 | 2019 | 243 | 0.640 |
Why?
|
| Ambulatory Care | 10 | 2012 | 2738 | 0.640 |
Why?
|
| Psychiatry | 11 | 2021 | 1706 | 0.640 |
Why?
|
| Interpersonal Relations | 16 | 2019 | 1439 | 0.640 |
Why?
|
| Follow-Up Studies | 50 | 2024 | 39223 | 0.640 |
Why?
|
| Health Status Indicators | 7 | 2012 | 980 | 0.630 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 9 | 2019 | 3077 | 0.620 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2021 | 944 | 0.610 |
Why?
|
| Hallucinations | 3 | 2018 | 361 | 0.610 |
Why?
|
| Community Mental Health Services | 8 | 2011 | 388 | 0.600 |
Why?
|
| Lung Transplantation | 7 | 2019 | 1139 | 0.600 |
Why?
|
| Outpatients | 4 | 2022 | 1544 | 0.600 |
Why?
|
| Social Conditions | 5 | 2012 | 126 | 0.600 |
Why?
|
| Prognosis | 32 | 2023 | 29264 | 0.600 |
Why?
|
| Hemoglobinopathies | 1 | 2018 | 95 | 0.600 |
Why?
|
| Pulmonary Medicine | 5 | 2017 | 217 | 0.600 |
Why?
|
| Post-Concussion Syndrome | 3 | 2019 | 223 | 0.590 |
Why?
|
| Health Services Research | 11 | 2018 | 1838 | 0.590 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 381 | 0.590 |
Why?
|
| Bulimia | 8 | 2013 | 398 | 0.570 |
Why?
|
| Delusions | 2 | 2018 | 300 | 0.570 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2021 | 891 | 0.570 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 5 | 2011 | 304 | 0.570 |
Why?
|
| Therapy, Computer-Assisted | 4 | 2019 | 274 | 0.570 |
Why?
|
| Belgium | 11 | 2021 | 104 | 0.560 |
Why?
|
| Personality Assessment | 14 | 2012 | 648 | 0.550 |
Why?
|
| Sex Distribution | 14 | 2019 | 2304 | 0.550 |
Why?
|
| Dissociative Disorders | 2 | 2022 | 232 | 0.550 |
Why?
|
| Americas | 7 | 2016 | 111 | 0.540 |
Why?
|
| Firesetting Behavior | 1 | 2015 | 5 | 0.540 |
Why?
|
| Cohort Studies | 58 | 2023 | 40939 | 0.540 |
Why?
|
| Personality Disorders | 5 | 2009 | 719 | 0.540 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 167 | 0.540 |
Why?
|
| Binge-Eating Disorder | 2 | 2019 | 153 | 0.530 |
Why?
|
| School Health Services | 3 | 2015 | 380 | 0.530 |
Why?
|
| Sleep Apnea Syndromes | 9 | 2020 | 965 | 0.530 |
Why?
|
| Parents | 17 | 2024 | 3448 | 0.530 |
Why?
|
| Schizophrenia | 17 | 2020 | 6923 | 0.530 |
Why?
|
| Earthquakes | 2 | 2019 | 179 | 0.530 |
Why?
|
| Survivors | 10 | 2023 | 2336 | 0.530 |
Why?
|
| Bronchodilator Agents | 2 | 2017 | 503 | 0.520 |
Why?
|
| Psychophysiologic Disorders | 6 | 2008 | 226 | 0.520 |
Why?
|
| South Africa | 13 | 2024 | 1740 | 0.520 |
Why?
|
| Aged, 80 and over | 50 | 2020 | 58361 | 0.520 |
Why?
|
| New Zealand | 7 | 2019 | 356 | 0.520 |
Why?
|
| Probability | 19 | 2009 | 2514 | 0.520 |
Why?
|
| Area Under Curve | 8 | 2017 | 1654 | 0.520 |
Why?
|
| France | 12 | 2020 | 515 | 0.520 |
Why?
|
| Social Support | 24 | 2021 | 2145 | 0.510 |
Why?
|
| Occupations | 9 | 2017 | 515 | 0.510 |
Why?
|
| Drug Tolerance | 1 | 2017 | 377 | 0.510 |
Why?
|
| Factor Analysis, Statistical | 9 | 2019 | 985 | 0.500 |
Why?
|
| Respiration Disorders | 2 | 2017 | 370 | 0.500 |
Why?
|
| Databases, Factual | 11 | 2021 | 7805 | 0.490 |
Why?
|
| Diabetic Neuropathies | 2 | 2017 | 399 | 0.490 |
Why?
|
| Oximetry | 1 | 2018 | 471 | 0.490 |
Why?
|
| Task Performance and Analysis | 3 | 2008 | 777 | 0.490 |
Why?
|
| Personality Inventory | 13 | 2014 | 1032 | 0.490 |
Why?
|
| Chi-Square Distribution | 14 | 2013 | 3500 | 0.480 |
Why?
|
| Cost-Benefit Analysis | 12 | 2021 | 5410 | 0.480 |
Why?
|
| Adolescent Health Services | 2 | 2014 | 217 | 0.480 |
Why?
|
| Treatment Outcome | 40 | 2024 | 64017 | 0.470 |
Why?
|
| Twins, Dizygotic | 30 | 2000 | 235 | 0.470 |
Why?
|
| Qatar | 5 | 2024 | 40 | 0.470 |
Why?
|
| Drug Therapy | 2 | 2007 | 501 | 0.470 |
Why?
|
| Latin America | 6 | 2023 | 384 | 0.470 |
Why?
|
| Disease Progression | 15 | 2020 | 13364 | 0.470 |
Why?
|
| Emigration and Immigration | 2 | 2007 | 403 | 0.470 |
Why?
|
| Drug Users | 2 | 2019 | 135 | 0.460 |
Why?
|
| Healthcare Disparities | 8 | 2024 | 3218 | 0.460 |
Why?
|
| Delivery of Health Care | 14 | 2021 | 5380 | 0.460 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 5 | 2017 | 467 | 0.460 |
Why?
|
| International Cooperation | 13 | 2015 | 1439 | 0.450 |
Why?
|
| Quality of Life | 16 | 2022 | 13044 | 0.450 |
Why?
|
| Pain | 9 | 2023 | 5040 | 0.440 |
Why?
|
| Achievement | 3 | 2017 | 290 | 0.440 |
Why?
|
| Survival Analysis | 26 | 2015 | 10252 | 0.440 |
Why?
|
| Family Relations | 4 | 2013 | 323 | 0.440 |
Why?
|
| Twins, Monozygotic | 30 | 2000 | 463 | 0.430 |
Why?
|
| Lebanon | 5 | 2019 | 232 | 0.430 |
Why?
|
| Checklist | 2 | 2019 | 844 | 0.430 |
Why?
|
| Homicide | 1 | 2015 | 292 | 0.430 |
Why?
|
| Child, Preschool | 30 | 2022 | 41390 | 0.420 |
Why?
|
| Educational Measurement | 2 | 2016 | 1221 | 0.420 |
Why?
|
| Unemployment | 8 | 2018 | 215 | 0.420 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2012 | 28 | 0.420 |
Why?
|
| Refugees | 2 | 2019 | 524 | 0.420 |
Why?
|
| Emigrants and Immigrants | 1 | 2018 | 527 | 0.410 |
Why?
|
| Home Nursing | 1 | 2012 | 91 | 0.410 |
Why?
|
| Homosexuality | 10 | 2000 | 262 | 0.410 |
Why?
|
| Statistics as Topic | 14 | 2017 | 2376 | 0.410 |
Why?
|
| Widowhood | 3 | 2001 | 53 | 0.410 |
Why?
|
| Afghanistan | 3 | 2021 | 84 | 0.410 |
Why?
|
| Peptic Ulcer | 1 | 2013 | 224 | 0.400 |
Why?
|
| Cluster Analysis | 8 | 2018 | 2719 | 0.400 |
Why?
|
| Spouse Abuse | 2 | 2011 | 179 | 0.400 |
Why?
|
| Heart Diseases | 5 | 2017 | 2802 | 0.390 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 689 | 0.390 |
Why?
|
| Iraq | 4 | 2021 | 92 | 0.390 |
Why?
|
| Health Policy | 10 | 2015 | 2687 | 0.390 |
Why?
|
| Efficiency, Organizational | 4 | 2009 | 697 | 0.390 |
Why?
|
| Courtship | 1 | 2011 | 32 | 0.390 |
Why?
|
| Arthritis | 4 | 2016 | 667 | 0.390 |
Why?
|
| Insurance, Pharmaceutical Services | 2 | 2007 | 337 | 0.380 |
Why?
|
| Grief | 3 | 2011 | 249 | 0.380 |
Why?
|
| Genetic Predisposition to Disease | 22 | 2024 | 17635 | 0.380 |
Why?
|
| Student Dropouts | 2 | 2009 | 27 | 0.380 |
Why?
|
| Student Health Services | 3 | 2019 | 41 | 0.380 |
Why?
|
| Bulimia Nervosa | 1 | 2013 | 206 | 0.380 |
Why?
|
| Minority Groups | 3 | 2020 | 1227 | 0.370 |
Why?
|
| Caregivers | 2 | 2013 | 2149 | 0.370 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2023 | 10057 | 0.370 |
Why?
|
| Oxygen | 9 | 2018 | 4208 | 0.370 |
Why?
|
| Mexico | 7 | 2019 | 723 | 0.370 |
Why?
|
| Respiratory Insufficiency | 2 | 2018 | 1211 | 0.370 |
Why?
|
| Population Dynamics | 1 | 2012 | 303 | 0.360 |
Why?
|
| Headache Disorders | 2 | 2014 | 134 | 0.360 |
Why?
|
| Floods | 1 | 2010 | 42 | 0.360 |
Why?
|
| Crime | 6 | 2015 | 213 | 0.360 |
Why?
|
| Germany | 11 | 2017 | 873 | 0.360 |
Why?
|
| Spouses | 2 | 2019 | 286 | 0.360 |
Why?
|
| Multivariate Analysis | 23 | 2017 | 12250 | 0.350 |
Why?
|
| Aftercare | 3 | 2023 | 885 | 0.350 |
Why?
|
| Emergency Service, Hospital | 8 | 2022 | 7766 | 0.350 |
Why?
|
| Veterans Health | 2 | 2021 | 218 | 0.340 |
Why?
|
| Pleurisy | 1 | 2009 | 53 | 0.340 |
Why?
|
| Louisiana | 5 | 2011 | 108 | 0.340 |
Why?
|
| Community Health Planning | 1 | 2010 | 166 | 0.340 |
Why?
|
| Peanut Hypersensitivity | 1 | 2011 | 167 | 0.340 |
Why?
|
| Causality | 15 | 2017 | 1285 | 0.340 |
Why?
|
| Physician-Patient Relations | 4 | 2022 | 3254 | 0.340 |
Why?
|
| Incidence | 35 | 2022 | 21146 | 0.340 |
Why?
|
| Familial Mediterranean Fever | 1 | 2009 | 63 | 0.340 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 815 | 0.340 |
Why?
|
| Lung Diseases | 6 | 2020 | 1890 | 0.340 |
Why?
|
| Asia | 6 | 2016 | 612 | 0.330 |
Why?
|
| Case-Control Studies | 26 | 2023 | 21904 | 0.330 |
Why?
|
| Acculturation | 2 | 2007 | 181 | 0.330 |
Why?
|
| Sensitivity and Specificity | 13 | 2021 | 14761 | 0.330 |
Why?
|
| Data Mining | 1 | 2014 | 543 | 0.320 |
Why?
|
| Executive Function | 2 | 2017 | 1375 | 0.320 |
Why?
|
| Telemedicine | 2 | 2023 | 2990 | 0.320 |
Why?
|
| Combat Disorders | 3 | 2014 | 302 | 0.320 |
Why?
|
| Recurrence | 14 | 2023 | 8422 | 0.320 |
Why?
|
| Psychomotor Agitation | 1 | 2011 | 302 | 0.320 |
Why?
|
| Cannabis | 5 | 2024 | 438 | 0.310 |
Why?
|
| Bullying | 3 | 2021 | 210 | 0.310 |
Why?
|
| Intention | 2 | 2023 | 346 | 0.310 |
Why?
|
| Peritonsillar Abscess | 1 | 2008 | 17 | 0.310 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2008 | 107 | 0.310 |
Why?
|
| Models, Economic | 2 | 2012 | 711 | 0.310 |
Why?
|
| Brain Concussion | 2 | 2016 | 1317 | 0.310 |
Why?
|
| Patient Advocacy | 2 | 2000 | 356 | 0.310 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4579 | 0.310 |
Why?
|
| Albuminuria | 1 | 2012 | 670 | 0.310 |
Why?
|
| Fantasy | 1 | 2007 | 68 | 0.300 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2019 | 322 | 0.300 |
Why?
|
| Gender Identity | 5 | 2009 | 699 | 0.300 |
Why?
|
| Bereavement | 4 | 2010 | 287 | 0.300 |
Why?
|
| Diagnosis, Differential | 18 | 2019 | 13042 | 0.300 |
Why?
|
| Patient Selection | 3 | 2019 | 4232 | 0.300 |
Why?
|
| Research Design | 14 | 2018 | 6118 | 0.300 |
Why?
|
| Patient Compliance | 4 | 2020 | 2708 | 0.290 |
Why?
|
| Foster Home Care | 1 | 2008 | 129 | 0.290 |
Why?
|
| Recovery of Function | 1 | 2017 | 2950 | 0.290 |
Why?
|
| Poland | 3 | 2018 | 184 | 0.290 |
Why?
|
| Food Supply | 1 | 2012 | 525 | 0.290 |
Why?
|
| Family Practice | 2 | 2006 | 517 | 0.280 |
Why?
|
| Polymorphism, Single Nucleotide | 15 | 2024 | 15657 | 0.280 |
Why?
|
| United States Department of Defense | 5 | 2021 | 32 | 0.280 |
Why?
|
| Epidemiology | 2 | 2000 | 287 | 0.280 |
Why?
|
| Specialization | 2 | 2014 | 777 | 0.280 |
Why?
|
| Attitude to Death | 2 | 2021 | 384 | 0.280 |
Why?
|
| Pleural Effusion | 1 | 2009 | 340 | 0.280 |
Why?
|
| Multilingualism | 1 | 2007 | 89 | 0.280 |
Why?
|
| Mexican Americans | 1 | 2007 | 163 | 0.270 |
Why?
|
| Prescription Fees | 1 | 2007 | 147 | 0.270 |
Why?
|
| Community-Institutional Relations | 1 | 2007 | 204 | 0.270 |
Why?
|
| Commerce | 2 | 2009 | 594 | 0.270 |
Why?
|
| Industry | 2 | 2008 | 365 | 0.270 |
Why?
|
| Attitude | 6 | 2007 | 783 | 0.270 |
Why?
|
| Genetic Loci | 6 | 2024 | 2614 | 0.270 |
Why?
|
| Insurance Claim Reporting | 1 | 2006 | 161 | 0.270 |
Why?
|
| Public Health | 6 | 2019 | 2634 | 0.270 |
Why?
|
| Cohort Effect | 6 | 2006 | 39 | 0.270 |
Why?
|
| Australia | 6 | 2020 | 1168 | 0.260 |
Why?
|
| Health Services Misuse | 1 | 2007 | 243 | 0.260 |
Why?
|
| Risk-Taking | 4 | 2022 | 990 | 0.260 |
Why?
|
| Health Personnel | 8 | 2024 | 3246 | 0.260 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 7355 | 0.260 |
Why?
|
| Self Psychology | 1 | 2005 | 8 | 0.260 |
Why?
|
| Combined Modality Therapy | 10 | 2023 | 8660 | 0.260 |
Why?
|
| Costs and Cost Analysis | 9 | 2010 | 1687 | 0.260 |
Why?
|
| Managed Care Programs | 3 | 2007 | 949 | 0.260 |
Why?
|
| Insurance, Health | 6 | 2013 | 2501 | 0.260 |
Why?
|
| Hypnotics and Sedatives | 1 | 2013 | 1177 | 0.250 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2014 | 1838 | 0.250 |
Why?
|
| Neck Pain | 3 | 2017 | 179 | 0.250 |
Why?
|
| Confidence Intervals | 10 | 2003 | 2978 | 0.250 |
Why?
|
| Algorithms | 12 | 2023 | 13984 | 0.250 |
Why?
|
| Health Promotion | 5 | 2021 | 2210 | 0.250 |
Why?
|
| Antipsychotic Agents | 6 | 2020 | 3079 | 0.250 |
Why?
|
| Personality | 9 | 2022 | 552 | 0.240 |
Why?
|
| Gambling | 1 | 2008 | 250 | 0.240 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 1127 | 0.240 |
Why?
|
| Wrist | 2 | 2023 | 225 | 0.240 |
Why?
|
| Hypertension, Pulmonary | 8 | 2005 | 1554 | 0.240 |
Why?
|
| Research | 7 | 2010 | 2001 | 0.230 |
Why?
|
| Pandemics | 10 | 2024 | 8607 | 0.230 |
Why?
|
| Tomography, Emission-Computed | 12 | 1996 | 1147 | 0.230 |
Why?
|
| Bisexuality | 3 | 2022 | 270 | 0.230 |
Why?
|
| Brazil | 8 | 2022 | 1288 | 0.230 |
Why?
|
| Personality Development | 6 | 2011 | 246 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2017 | 3374 | 0.230 |
Why?
|
| DNA Methylation | 5 | 2022 | 4315 | 0.230 |
Why?
|
| Predictive Value of Tests | 12 | 2016 | 15164 | 0.230 |
Why?
|
| Obesity Hypoventilation Syndrome | 2 | 2010 | 17 | 0.220 |
Why?
|
| Object Attachment | 3 | 2023 | 316 | 0.220 |
Why?
|
| Students, Medical | 1 | 2016 | 1887 | 0.220 |
Why?
|
| Japan | 5 | 2017 | 1377 | 0.220 |
Why?
|
| Curriculum | 1 | 2016 | 3633 | 0.220 |
Why?
|
| Neck | 1 | 2008 | 713 | 0.220 |
Why?
|
| Sociology | 1 | 2002 | 21 | 0.210 |
Why?
|
| Social Welfare | 3 | 2000 | 91 | 0.210 |
Why?
|
| Social Problems | 1 | 2023 | 110 | 0.210 |
Why?
|
| Radiology | 1 | 2016 | 2131 | 0.210 |
Why?
|
| Internal Capsule | 1 | 2023 | 125 | 0.210 |
Why?
|
| Back Pain | 3 | 2017 | 546 | 0.210 |
Why?
|
| Tissue Donors | 1 | 2011 | 2234 | 0.210 |
Why?
|
| Ontario | 8 | 2002 | 386 | 0.210 |
Why?
|
| Primary Health Care | 8 | 2022 | 4624 | 0.210 |
Why?
|
| Clergy | 1 | 2003 | 83 | 0.210 |
Why?
|
| Marijuana Smoking | 2 | 2019 | 252 | 0.200 |
Why?
|
| Self Concept | 7 | 2018 | 1033 | 0.200 |
Why?
|
| Smoking Cessation | 3 | 2009 | 2083 | 0.200 |
Why?
|
| Education | 5 | 2007 | 543 | 0.200 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2005 | 436 | 0.200 |
Why?
|
| Pollen | 1 | 2001 | 81 | 0.200 |
Why?
|
| Multifactorial Inheritance | 6 | 2019 | 1258 | 0.200 |
Why?
|
| Schools | 7 | 2015 | 1443 | 0.200 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2001 | 59 | 0.200 |
Why?
|
| Seasons | 1 | 2007 | 1511 | 0.200 |
Why?
|
| Women | 3 | 1998 | 232 | 0.200 |
Why?
|
| Social Stigma | 3 | 2018 | 717 | 0.200 |
Why?
|
| Dreams | 1 | 2022 | 148 | 0.190 |
Why?
|
| Referral and Consultation | 5 | 2012 | 3573 | 0.190 |
Why?
|
| Sexual Behavior | 9 | 2022 | 2072 | 0.190 |
Why?
|
| Headache | 1 | 2009 | 1238 | 0.190 |
Why?
|
| Pneumonectomy | 9 | 2004 | 1113 | 0.190 |
Why?
|
| Nuclear Family | 1 | 2002 | 318 | 0.190 |
Why?
|
| Polysomnography | 6 | 2014 | 1787 | 0.190 |
Why?
|
| Somatoform Disorders | 6 | 2010 | 426 | 0.190 |
Why?
|
| Cities | 4 | 2019 | 518 | 0.190 |
Why?
|
| Emotions | 5 | 2022 | 2684 | 0.190 |
Why?
|
| Repressor Proteins | 3 | 2020 | 3021 | 0.190 |
Why?
|
| Telephone | 4 | 2012 | 624 | 0.180 |
Why?
|
| New Orleans | 2 | 2010 | 27 | 0.180 |
Why?
|
| Colonic Diseases, Functional | 1 | 2000 | 38 | 0.180 |
Why?
|
| Child Rearing | 4 | 1997 | 74 | 0.180 |
Why?
|
| Migraine Disorders | 2 | 2010 | 1645 | 0.180 |
Why?
|
| Psychotherapy, Group | 1 | 2024 | 413 | 0.180 |
Why?
|
| Workers' Compensation | 1 | 2001 | 152 | 0.180 |
Why?
|
| Health Services | 4 | 2024 | 760 | 0.180 |
Why?
|
| Occupational Health Services | 2 | 2014 | 153 | 0.180 |
Why?
|
| Obesity | 8 | 2020 | 12868 | 0.180 |
Why?
|
| Insurance, Psychiatric | 4 | 2009 | 69 | 0.180 |
Why?
|
| Occupational Exposure | 2 | 2008 | 1796 | 0.180 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2020 | 370 | 0.180 |
Why?
|
| Africa | 3 | 2017 | 696 | 0.170 |
Why?
|
| Homosexuality, Female | 1 | 2001 | 158 | 0.170 |
Why?
|
| Affect | 2 | 2023 | 1478 | 0.170 |
Why?
|
| Sick Role | 5 | 2007 | 237 | 0.170 |
Why?
|
| Osteoarthritis | 1 | 2007 | 1049 | 0.170 |
Why?
|
| Sulfotransferases | 1 | 2020 | 151 | 0.170 |
Why?
|
| Population | 2 | 2012 | 142 | 0.170 |
Why?
|
| Nigeria | 3 | 2023 | 764 | 0.170 |
Why?
|
| Psychotherapy, Brief | 1 | 2020 | 114 | 0.170 |
Why?
|
| Rape | 1 | 2019 | 133 | 0.170 |
Why?
|
| Syria | 1 | 2019 | 78 | 0.160 |
Why?
|
| Antisocial Personality Disorder | 2 | 1997 | 226 | 0.160 |
Why?
|
| Social Responsibility | 1 | 2021 | 391 | 0.160 |
Why?
|
| Fungi | 1 | 2001 | 333 | 0.160 |
Why?
|
| Environment | 4 | 2019 | 1123 | 0.160 |
Why?
|
| Online Systems | 1 | 2019 | 184 | 0.160 |
Why?
|
| Netherlands | 6 | 2023 | 2175 | 0.160 |
Why?
|
| Terminology as Topic | 9 | 2007 | 1547 | 0.160 |
Why?
|
| Child Abuse, Sexual | 1 | 2001 | 384 | 0.160 |
Why?
|
| Men | 1 | 1998 | 63 | 0.160 |
Why?
|
| Cardiovascular Diseases | 7 | 2020 | 15433 | 0.160 |
Why?
|
| Single Person | 3 | 1998 | 33 | 0.160 |
Why?
|
| Medicine | 2 | 2006 | 950 | 0.160 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 1950 | 0.160 |
Why?
|
| Illegitimacy | 1 | 1997 | 4 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 11 | 2010 | 2227 | 0.160 |
Why?
|
| Respiratory Paralysis | 2 | 2016 | 31 | 0.150 |
Why?
|
| Hypnosis | 1 | 1998 | 83 | 0.150 |
Why?
|
| Disaster Planning | 3 | 2009 | 563 | 0.150 |
Why?
|
| Positive-Pressure Respiration | 2 | 1999 | 637 | 0.150 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2019 | 124 | 0.150 |
Why?
|
| Rectum | 3 | 2005 | 907 | 0.150 |
Why?
|
| Behavior | 2 | 2019 | 559 | 0.150 |
Why?
|
| California | 4 | 2007 | 1421 | 0.150 |
Why?
|
| Precipitating Factors | 2 | 2021 | 52 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 7269 | 0.150 |
Why?
|
| Peer Group | 4 | 2019 | 650 | 0.150 |
Why?
|
| Quality of Health Care | 7 | 2019 | 4385 | 0.150 |
Why?
|
| Opportunistic Infections | 1 | 2020 | 384 | 0.150 |
Why?
|
| Michigan | 10 | 1999 | 350 | 0.150 |
Why?
|
| World War II | 1 | 2017 | 59 | 0.150 |
Why?
|
| Bayes Theorem | 4 | 2023 | 2332 | 0.150 |
Why?
|
| Respiratory Tract Diseases | 2 | 2017 | 727 | 0.140 |
Why?
|
| Explosive Agents | 1 | 2017 | 26 | 0.140 |
Why?
|
| Behavior, Addictive | 2 | 2008 | 457 | 0.140 |
Why?
|
| Trauma Severity Indices | 4 | 2021 | 481 | 0.140 |
Why?
|
| Hospitalization | 7 | 2024 | 10422 | 0.140 |
Why?
|
| Cognition | 5 | 2022 | 6844 | 0.140 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1779 | 0.140 |
Why?
|
| Cholestanols | 1 | 2016 | 8 | 0.140 |
Why?
|
| Filipin | 1 | 2016 | 13 | 0.140 |
Why?
|
| Epigenesis, Genetic | 5 | 2022 | 3686 | 0.140 |
Why?
|
| Hexosaminidases | 1 | 2016 | 53 | 0.140 |
Why?
|
| United States Substance Abuse and Mental Health Services Administration | 2 | 2008 | 21 | 0.140 |
Why?
|
| Airway Obstruction | 2 | 2020 | 660 | 0.140 |
Why?
|
| Drug Therapy, Combination | 4 | 2020 | 6493 | 0.140 |
Why?
|
| Infant | 14 | 2019 | 35447 | 0.140 |
Why?
|
| Patient Discharge | 2 | 2023 | 3356 | 0.140 |
Why?
|
| Translating | 3 | 2014 | 149 | 0.140 |
Why?
|
| Pilot Projects | 7 | 2021 | 8413 | 0.140 |
Why?
|
| Awareness | 1 | 2000 | 643 | 0.140 |
Why?
|
| Vasodilator Agents | 1 | 2020 | 974 | 0.140 |
Why?
|
| Airway Management | 1 | 2020 | 329 | 0.140 |
Why?
|
| Propensity Score | 3 | 2019 | 1828 | 0.140 |
Why?
|
| Television | 2 | 1989 | 406 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2016 | 5858 | 0.140 |
Why?
|
| Homosexuality, Male | 2 | 2001 | 1247 | 0.130 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2016 | 51 | 0.130 |
Why?
|
| Middle East | 1 | 2016 | 224 | 0.130 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 215 | 0.130 |
Why?
|
| Pregnancy in Adolescence | 1 | 1997 | 160 | 0.130 |
Why?
|
| Brain | 16 | 2023 | 26598 | 0.130 |
Why?
|
| Self Care | 3 | 2019 | 787 | 0.130 |
Why?
|
| Selection Bias | 1 | 1997 | 375 | 0.130 |
Why?
|
| Psychotropic Drugs | 4 | 2007 | 893 | 0.130 |
Why?
|
| Immunocompromised Host | 2 | 2018 | 847 | 0.130 |
Why?
|
| Pulmonary Gas Exchange | 4 | 2005 | 382 | 0.130 |
Why?
|
| Epilepsy | 1 | 2011 | 3319 | 0.130 |
Why?
|
| Autopsy | 1 | 2019 | 1024 | 0.130 |
Why?
|
| CpG Islands | 1 | 2020 | 1219 | 0.130 |
Why?
|
| Morbidity | 5 | 2011 | 1784 | 0.130 |
Why?
|
| Time | 1 | 2017 | 548 | 0.130 |
Why?
|
| Forced Expiratory Volume | 4 | 2013 | 1748 | 0.130 |
Why?
|
| Prejudice | 1 | 1999 | 571 | 0.130 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2017 | 259 | 0.130 |
Why?
|
| Penile Prosthesis | 2 | 1994 | 38 | 0.130 |
Why?
|
| Commitment of Mentally Ill | 1 | 2015 | 94 | 0.130 |
Why?
|
| Insurance Coverage | 3 | 2012 | 1931 | 0.120 |
Why?
|
| Blood Glucose | 8 | 2013 | 6318 | 0.120 |
Why?
|
| Economic Recession | 1 | 2015 | 78 | 0.120 |
Why?
|
| Early Diagnosis | 4 | 2019 | 1181 | 0.120 |
Why?
|
| Religion | 1 | 2018 | 364 | 0.120 |
Why?
|
| Disease | 1 | 2020 | 674 | 0.120 |
Why?
|
| Switzerland | 3 | 2012 | 259 | 0.120 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 448 | 0.120 |
Why?
|
| Bronchoscopy | 1 | 2020 | 867 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 2 | 2008 | 459 | 0.120 |
Why?
|
| Patient Preference | 1 | 2021 | 899 | 0.120 |
Why?
|
| Allergens | 1 | 2001 | 1339 | 0.120 |
Why?
|
| Colombia | 3 | 2019 | 260 | 0.120 |
Why?
|
| Aging | 4 | 2019 | 8752 | 0.120 |
Why?
|
| Terrorism | 1 | 2017 | 211 | 0.120 |
Why?
|
| Proportional Hazards Models | 8 | 2020 | 12423 | 0.120 |
Why?
|
| Respiratory Function Tests | 7 | 2013 | 1631 | 0.120 |
Why?
|
| Pruritus | 1 | 2017 | 362 | 0.120 |
Why?
|
| Dibenzocycloheptenes | 1 | 2013 | 27 | 0.120 |
Why?
|
| Cephalosporins | 1 | 1995 | 202 | 0.120 |
Why?
|
| Occupational Medicine | 1 | 2014 | 115 | 0.120 |
Why?
|
| Counseling | 4 | 2022 | 1535 | 0.110 |
Why?
|
| Penicillium chrysogenum | 1 | 2013 | 7 | 0.110 |
Why?
|
| Pulmonary Circulation | 5 | 1999 | 750 | 0.110 |
Why?
|
| Thrombosis | 1 | 2008 | 3035 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 2009 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 641 | 0.110 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 827 | 0.110 |
Why?
|
| Poverty Areas | 2 | 2011 | 274 | 0.110 |
Why?
|
| Behavioral Research | 2 | 2016 | 53 | 0.110 |
Why?
|
| Cystic Fibrosis | 2 | 2013 | 1184 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 4 | 2010 | 2729 | 0.110 |
Why?
|
| Health Behavior | 2 | 2007 | 2648 | 0.110 |
Why?
|
| Patient Satisfaction | 3 | 2020 | 3433 | 0.110 |
Why?
|
| Public Policy | 3 | 2014 | 577 | 0.110 |
Why?
|
| Linear Models | 4 | 2019 | 5965 | 0.110 |
Why?
|
| Information Services | 1 | 2014 | 241 | 0.110 |
Why?
|
| Analysis of Variance | 6 | 2010 | 6352 | 0.110 |
Why?
|
| Streptomyces | 1 | 2013 | 90 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2007 | 4344 | 0.110 |
Why?
|
| Feeding Behavior | 4 | 2008 | 3204 | 0.110 |
Why?
|
| Fruit | 2 | 1995 | 1151 | 0.110 |
Why?
|
| Virginia | 11 | 1997 | 120 | 0.110 |
Why?
|
| Vegetables | 2 | 1995 | 1186 | 0.110 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2013 | 60 | 0.110 |
Why?
|
| Genotype | 7 | 2019 | 12970 | 0.110 |
Why?
|
| Motivation | 3 | 2019 | 1990 | 0.110 |
Why?
|
| Death | 2 | 2016 | 675 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 2336 | 0.110 |
Why?
|
| Parent-Child Relations | 3 | 2010 | 747 | 0.110 |
Why?
|
| Colchicine | 2 | 2013 | 247 | 0.110 |
Why?
|
| Alcoholic Beverages | 1 | 2014 | 266 | 0.100 |
Why?
|
| Personal Satisfaction | 2 | 2017 | 645 | 0.100 |
Why?
|
| Military Medicine | 1 | 2014 | 179 | 0.100 |
Why?
|
| Blast Injuries | 1 | 2016 | 316 | 0.100 |
Why?
|
| Models, Genetic | 25 | 1996 | 3489 | 0.100 |
Why?
|
| Intradermal Tests | 1 | 2011 | 44 | 0.100 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 2125 | 0.100 |
Why?
|
| Nocardia asteroides | 1 | 1991 | 9 | 0.100 |
Why?
|
| Program Evaluation | 3 | 2015 | 2502 | 0.100 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 4327 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3246 | 0.100 |
Why?
|
| Drug Approval | 1 | 1999 | 786 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 3766 | 0.100 |
Why?
|
| Vasovasostomy | 1 | 1991 | 6 | 0.100 |
Why?
|
| Workload | 3 | 2004 | 857 | 0.100 |
Why?
|
| Lung Neoplasms | 11 | 2005 | 13263 | 0.100 |
Why?
|
| Nocardia Infections | 1 | 1991 | 19 | 0.100 |
Why?
|
| Hypertension | 6 | 2020 | 8614 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1367 | 0.100 |
Why?
|
| Pericarditis, Constrictive | 1 | 1991 | 42 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2016 | 1104 | 0.100 |
Why?
|
| Respiratory Mechanics | 1 | 1996 | 696 | 0.100 |
Why?
|
| Calibration | 2 | 2005 | 820 | 0.100 |
Why?
|
| Partial Pressure | 3 | 2001 | 253 | 0.100 |
Why?
|
| Phenotype | 11 | 2023 | 16484 | 0.100 |
Why?
|
| Medicaid | 3 | 2006 | 2776 | 0.100 |
Why?
|
| Cell Cycle Proteins | 2 | 2020 | 3491 | 0.100 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 605 | 0.100 |
Why?
|
| Body Mass Index | 6 | 2014 | 12821 | 0.100 |
Why?
|
| Blood Pressure | 5 | 2004 | 8635 | 0.100 |
Why?
|
| Naphthyridines | 1 | 1992 | 121 | 0.100 |
Why?
|
| Financing, Personal | 1 | 2014 | 310 | 0.100 |
Why?
|
| Syndrome | 3 | 2010 | 3261 | 0.100 |
Why?
|
| Penile Induration | 1 | 1991 | 16 | 0.100 |
Why?
|
| Inpatients | 1 | 2023 | 2549 | 0.100 |
Why?
|
| Pulmonary Artery | 3 | 1999 | 1944 | 0.100 |
Why?
|
| Happiness | 1 | 2012 | 169 | 0.100 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2008 | 447 | 0.100 |
Why?
|
| Peritoneal Diseases | 1 | 1991 | 74 | 0.100 |
Why?
|
| Respiratory System Agents | 1 | 2010 | 29 | 0.100 |
Why?
|
| Asthma | 4 | 2014 | 6089 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 1992 | 185 | 0.090 |
Why?
|
| Israel | 2 | 2019 | 807 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2005 | 5284 | 0.090 |
Why?
|
| Sick Leave | 2 | 2008 | 109 | 0.090 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1991 | 248 | 0.090 |
Why?
|
| Computer Simulation | 3 | 2016 | 6190 | 0.090 |
Why?
|
| Peritoneal Neoplasms | 1 | 2016 | 678 | 0.090 |
Why?
|
| Amygdala | 3 | 2023 | 1340 | 0.090 |
Why?
|
| Dysthymic Disorder | 2 | 2007 | 74 | 0.090 |
Why?
|
| Pain Measurement | 4 | 2017 | 3469 | 0.090 |
Why?
|
| Health Expenditures | 6 | 2010 | 2371 | 0.090 |
Why?
|
| Health Planning | 1 | 2011 | 237 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1858 | 0.090 |
Why?
|
| Cause of Death | 3 | 2016 | 3628 | 0.090 |
Why?
|
| Gram-Negative Bacteria | 1 | 1992 | 274 | 0.090 |
Why?
|
| Radiography, Thoracic | 4 | 2017 | 1279 | 0.090 |
Why?
|
| Mississippi | 1 | 2009 | 89 | 0.090 |
Why?
|
| Alabama | 1 | 2009 | 101 | 0.090 |
Why?
|
| Fluoroquinolones | 1 | 1992 | 305 | 0.090 |
Why?
|
| Postoperative Complications | 14 | 2018 | 15459 | 0.090 |
Why?
|
| Cultural Characteristics | 1 | 2011 | 262 | 0.090 |
Why?
|
| HIV Seropositivity | 4 | 1993 | 967 | 0.090 |
Why?
|
| Patient Care Team | 3 | 2013 | 2555 | 0.090 |
Why?
|
| Glucose Intolerance | 1 | 2013 | 576 | 0.090 |
Why?
|
| Viruses | 1 | 2013 | 377 | 0.090 |
Why?
|
| Women's Rights | 1 | 1989 | 69 | 0.090 |
Why?
|
| Safety Management | 1 | 2015 | 782 | 0.080 |
Why?
|
| Paternal Deprivation | 3 | 2010 | 10 | 0.080 |
Why?
|
| Capacity Building | 1 | 2011 | 252 | 0.080 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3136 | 0.080 |
Why?
|
| Ventricular Pressure | 1 | 2010 | 199 | 0.080 |
Why?
|
| Space-Time Clustering | 1 | 1988 | 49 | 0.080 |
Why?
|
| Tubulin Modulators | 1 | 2009 | 111 | 0.080 |
Why?
|
| Family Conflict | 1 | 2009 | 95 | 0.080 |
Why?
|
| Italy | 1 | 2011 | 831 | 0.080 |
Why?
|
| Vital Capacity | 4 | 2013 | 932 | 0.080 |
Why?
|
| Evidence-Based Practice | 3 | 2017 | 503 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2016 | 11626 | 0.080 |
Why?
|
| Sleep | 6 | 2023 | 4619 | 0.080 |
Why?
|
| Supine Position | 2 | 2000 | 205 | 0.080 |
Why?
|
| Multilevel Analysis | 2 | 2019 | 145 | 0.080 |
Why?
|
| Child Care | 1 | 1989 | 119 | 0.080 |
Why?
|
| Cost Control | 3 | 2001 | 624 | 0.080 |
Why?
|
| Cetrimonium Compounds | 1 | 2008 | 4 | 0.080 |
Why?
|
| Psychological Theory | 2 | 2020 | 168 | 0.080 |
Why?
|
| Myristates | 1 | 2008 | 13 | 0.080 |
Why?
|
| Diabetes Mellitus | 4 | 2020 | 5799 | 0.080 |
Why?
|
| Urbanization | 2 | 2019 | 101 | 0.080 |
Why?
|
| Reference Values | 3 | 2005 | 4994 | 0.080 |
Why?
|
| Maternal Deprivation | 3 | 2010 | 48 | 0.080 |
Why?
|
| Chile | 3 | 2017 | 242 | 0.080 |
Why?
|
| Simethicone | 1 | 2008 | 15 | 0.080 |
Why?
|
| Periodicity | 1 | 2010 | 362 | 0.080 |
Why?
|
| Nicotinic Acids | 1 | 2008 | 33 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 2112 | 0.080 |
Why?
|
| Nepal | 2 | 2023 | 297 | 0.080 |
Why?
|
| Musculoskeletal Diseases | 2 | 2020 | 590 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2016 | 2253 | 0.080 |
Why?
|
| Stearic Acids | 1 | 2008 | 53 | 0.080 |
Why?
|
| Qualitative Research | 2 | 2020 | 2778 | 0.080 |
Why?
|
| Ventricular Function | 1 | 2010 | 416 | 0.080 |
Why?
|
| Brain Mapping | 6 | 2005 | 6647 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3652 | 0.080 |
Why?
|
| Relief Work | 1 | 2009 | 136 | 0.080 |
Why?
|
| Stents | 1 | 2020 | 3311 | 0.080 |
Why?
|
| Infant Care | 2 | 2000 | 178 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 1 | 2014 | 936 | 0.080 |
Why?
|
| Registries | 14 | 2019 | 8216 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4121 | 0.080 |
Why?
|
| Housing | 1 | 2012 | 673 | 0.080 |
Why?
|
| Washington | 1 | 2008 | 314 | 0.080 |
Why?
|
| Basal Ganglia | 3 | 1987 | 546 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 2089 | 0.080 |
Why?
|
| Nootropic Agents | 1 | 2008 | 159 | 0.080 |
Why?
|
| Pedigree | 3 | 2009 | 4637 | 0.070 |
Why?
|
| Bioethical Issues | 1 | 2008 | 124 | 0.070 |
Why?
|
| Drug and Narcotic Control | 1 | 2008 | 147 | 0.070 |
Why?
|
| Hemodynamics | 7 | 2005 | 4216 | 0.070 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2017 | 124 | 0.070 |
Why?
|
| Maternal Age | 2 | 2003 | 810 | 0.070 |
Why?
|
| Denmark | 2 | 2020 | 766 | 0.070 |
Why?
|
| Perception | 3 | 2015 | 1199 | 0.070 |
Why?
|
| Tobacco Use Cessation | 1 | 2008 | 96 | 0.070 |
Why?
|
| Convalescence | 1 | 2007 | 104 | 0.070 |
Why?
|
| Pain, Intractable | 1 | 2008 | 131 | 0.070 |
Why?
|
| Veterans Disability Claims | 1 | 2006 | 15 | 0.070 |
Why?
|
| Markov Chains | 2 | 2009 | 979 | 0.070 |
Why?
|
| Pericardium | 1 | 1991 | 672 | 0.070 |
Why?
|
| Health Care Rationing | 1 | 2010 | 435 | 0.070 |
Why?
|
| Graft Rejection | 3 | 2017 | 4370 | 0.070 |
Why?
|
| Circadian Rhythm | 4 | 2021 | 2557 | 0.070 |
Why?
|
| Georgia | 1 | 2007 | 187 | 0.070 |
Why?
|
| Jugular Veins | 1 | 2008 | 204 | 0.070 |
Why?
|
| Lung Diseases, Fungal | 2 | 1998 | 125 | 0.070 |
Why?
|
| South America | 2 | 2016 | 181 | 0.070 |
Why?
|
| Public Sector | 1 | 2008 | 266 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1553 | 0.070 |
Why?
|
| Infant, Newborn | 7 | 2023 | 25903 | 0.070 |
Why?
|
| Urban Health | 1 | 2009 | 547 | 0.070 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 7008 | 0.070 |
Why?
|
| Stereotyping | 1 | 2008 | 240 | 0.070 |
Why?
|
| Sudden Infant Death | 2 | 2000 | 296 | 0.070 |
Why?
|
| Case Management | 1 | 2008 | 285 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 1996 | 2654 | 0.070 |
Why?
|
| Hospitals, University | 2 | 2020 | 576 | 0.070 |
Why?
|
| Individuality | 2 | 2006 | 303 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2016 | 5006 | 0.070 |
Why?
|
| Language | 1 | 2015 | 1506 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2010 | 1426 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2006 | 1700 | 0.070 |
Why?
|
| Peru | 2 | 2019 | 901 | 0.070 |
Why?
|
| Burns | 1 | 2017 | 1839 | 0.070 |
Why?
|
| Attitude of Health Personnel | 3 | 2015 | 3871 | 0.070 |
Why?
|
| Mass Media | 1 | 1988 | 306 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 980 | 0.070 |
Why?
|
| Hematologic Diseases | 2 | 2006 | 497 | 0.070 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 1485 | 0.070 |
Why?
|
| Ketones | 1 | 2006 | 182 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2013 | 1867 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2000 | 1010 | 0.060 |
Why?
|
| Interdisciplinary Communication | 2 | 2013 | 948 | 0.060 |
Why?
|
| Fever | 2 | 2009 | 1627 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 3 | 1998 | 1676 | 0.060 |
Why?
|
| Nutritional Status | 1 | 2013 | 1610 | 0.060 |
Why?
|
| Hospitals, Psychiatric | 1 | 2006 | 332 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3761 | 0.060 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2010 | 748 | 0.060 |
Why?
|
| Quadruplets | 1 | 1984 | 9 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4943 | 0.060 |
Why?
|
| Testicular Hydrocele | 1 | 1984 | 28 | 0.060 |
Why?
|
| Private Sector | 1 | 2008 | 397 | 0.060 |
Why?
|
| Amitriptyline | 1 | 2005 | 110 | 0.060 |
Why?
|
| Psychological Tests | 3 | 2006 | 649 | 0.060 |
Why?
|
| Carcinoma | 1 | 2016 | 2385 | 0.060 |
Why?
|
| Cisplatin | 2 | 2005 | 1664 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3757 | 0.060 |
Why?
|
| Bronchi | 3 | 2017 | 851 | 0.060 |
Why?
|
| Phrenic Nerve | 1 | 2004 | 79 | 0.060 |
Why?
|
| Climate Change | 1 | 2010 | 435 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10914 | 0.060 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2006 | 266 | 0.060 |
Why?
|
| Health Priorities | 1 | 2007 | 381 | 0.060 |
Why?
|
| Varicocele | 1 | 1984 | 77 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2010 | 1569 | 0.060 |
Why?
|
| National Health Programs | 2 | 2000 | 445 | 0.060 |
Why?
|
| Emergencies | 1 | 1991 | 1174 | 0.060 |
Why?
|
| Internal Medicine | 2 | 2005 | 1021 | 0.060 |
Why?
|
| Dyspnea | 2 | 2010 | 1316 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2013 | 2129 | 0.060 |
Why?
|
| Speech | 2 | 2000 | 553 | 0.060 |
Why?
|
| Child Welfare | 1 | 2008 | 521 | 0.060 |
Why?
|
| Bacteria | 1 | 1995 | 2145 | 0.060 |
Why?
|
| Health Care Reform | 2 | 2007 | 1272 | 0.060 |
Why?
|
| Canada | 2 | 2007 | 2081 | 0.060 |
Why?
|
| Twins | 3 | 1994 | 339 | 0.060 |
Why?
|
| Social Perception | 2 | 1993 | 425 | 0.060 |
Why?
|
| Aerospace Medicine | 1 | 2004 | 91 | 0.060 |
Why?
|
| Allelic Imbalance | 1 | 2003 | 77 | 0.060 |
Why?
|
| Vinblastine | 1 | 2005 | 503 | 0.060 |
Why?
|
| Digestive System Diseases | 1 | 2005 | 147 | 0.060 |
Why?
|
| Patient Care Management | 1 | 2006 | 308 | 0.060 |
Why?
|
| Hospital Costs | 2 | 2006 | 983 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2023 | 35798 | 0.060 |
Why?
|
| Private Practice | 2 | 1999 | 155 | 0.060 |
Why?
|
| Neurobiology | 1 | 2024 | 135 | 0.060 |
Why?
|
| Dilatation | 2 | 2005 | 303 | 0.060 |
Why?
|
| Neoplasms | 5 | 2020 | 21976 | 0.050 |
Why?
|
| Biological Availability | 1 | 2023 | 398 | 0.050 |
Why?
|
| Mortality | 1 | 2014 | 2899 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2009 | 1062 | 0.050 |
Why?
|
| Beds | 1 | 2003 | 47 | 0.050 |
Why?
|
| Somatosensory Cortex | 1 | 1987 | 530 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2018 | 3349 | 0.050 |
Why?
|
| Critical Illness | 1 | 2015 | 2697 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2009 | 808 | 0.050 |
Why?
|
| Ethics, Medical | 1 | 1988 | 794 | 0.050 |
Why?
|
| Lung | 6 | 2017 | 9990 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2008 | 1994 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2016 | 2822 | 0.050 |
Why?
|
| Phytotherapy | 2 | 2002 | 296 | 0.050 |
Why?
|
| Military Psychiatry | 1 | 2021 | 21 | 0.050 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 1127 | 0.050 |
Why?
|
| Health Benefit Plans, Employee | 2 | 2007 | 333 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2005 | 367 | 0.050 |
Why?
|
| Frontal Lobe | 4 | 2020 | 1398 | 0.050 |
Why?
|
| Deoxyglucose | 8 | 1989 | 335 | 0.050 |
Why?
|
| Psychology | 3 | 2009 | 357 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 1159 | 0.050 |
Why?
|
| Attention | 3 | 2010 | 2398 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2017 | 20346 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2021 | 135 | 0.050 |
Why?
|
| Biopsy | 3 | 2017 | 6771 | 0.050 |
Why?
|
| North America | 2 | 1998 | 1255 | 0.050 |
Why?
|
| Defense Mechanisms | 3 | 1999 | 178 | 0.050 |
Why?
|
| Testis | 1 | 1984 | 804 | 0.050 |
Why?
|
| Prone Position | 2 | 2000 | 194 | 0.050 |
Why?
|
| Voluntary Health Agencies | 1 | 2000 | 39 | 0.050 |
Why?
|
| Self Disclosure | 3 | 2010 | 251 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 1270 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 2313 | 0.050 |
Why?
|
| Deoxycytidine | 1 | 2005 | 839 | 0.050 |
Why?
|
| Least-Squares Analysis | 1 | 2001 | 379 | 0.050 |
Why?
|
| Mutation | 3 | 2017 | 29981 | 0.050 |
Why?
|
| Gyrus Cinguli | 2 | 2023 | 1091 | 0.050 |
Why?
|
| Kynurenine | 1 | 2020 | 138 | 0.040 |
Why?
|
| Male Urogenital Diseases | 1 | 2020 | 48 | 0.040 |
Why?
|
| Osteoporosis | 1 | 2010 | 1582 | 0.040 |
Why?
|
| Mothers | 2 | 1994 | 2190 | 0.040 |
Why?
|
| Public Assistance | 1 | 2000 | 47 | 0.040 |
Why?
|
| Female Urogenital Diseases | 1 | 2020 | 53 | 0.040 |
Why?
|
| Blood Loss, Surgical | 3 | 1998 | 658 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 1636 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2011 | 12202 | 0.040 |
Why?
|
| Database Management Systems | 1 | 2021 | 269 | 0.040 |
Why?
|
| Imitative Behavior | 2 | 1989 | 34 | 0.040 |
Why?
|
| Anisotropy | 1 | 2023 | 1280 | 0.040 |
Why?
|
| Carbon Dioxide | 4 | 2001 | 1162 | 0.040 |
Why?
|
| Medical History Taking | 2 | 2021 | 782 | 0.040 |
Why?
|
| Carcinoma, Bronchogenic | 2 | 1996 | 85 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2004 | 732 | 0.040 |
Why?
|
| Northern Ireland | 1 | 2018 | 37 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10256 | 0.040 |
Why?
|
| Genetics, Behavioral | 1 | 2019 | 53 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2000 | 303 | 0.040 |
Why?
|
| Portugal | 1 | 2018 | 89 | 0.040 |
Why?
|
| Romania | 1 | 2018 | 96 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 2001 | 419 | 0.040 |
Why?
|
| Mother-Child Relations | 1 | 2003 | 482 | 0.040 |
Why?
|
| Medical Records | 1 | 2004 | 1412 | 0.040 |
Why?
|
| Sjogren's Syndrome | 1 | 2020 | 234 | 0.040 |
Why?
|
| Utilization Review | 2 | 2011 | 392 | 0.040 |
Why?
|
| Ascites | 1 | 2020 | 342 | 0.040 |
Why?
|
| Arousal | 3 | 2022 | 1164 | 0.040 |
Why?
|
| Acute Disease | 2 | 2008 | 7221 | 0.040 |
Why?
|
| Survival Rate | 7 | 2010 | 12802 | 0.040 |
Why?
|
| Medically Uninsured | 2 | 2002 | 858 | 0.040 |
Why?
|
| Hantavirus Pulmonary Syndrome | 1 | 1998 | 10 | 0.040 |
Why?
|
| Actuarial Analysis | 2 | 1995 | 378 | 0.040 |
Why?
|
| Thinking | 1 | 2001 | 318 | 0.040 |
Why?
|
| Seasonal Affective Disorder | 1 | 1998 | 49 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2022 | 514 | 0.040 |
Why?
|
| Extinction, Psychological | 1 | 2021 | 379 | 0.040 |
Why?
|
| Graft Survival | 3 | 2018 | 3731 | 0.040 |
Why?
|
| Anorexia Nervosa | 2 | 2006 | 1394 | 0.040 |
Why?
|
| Spirometry | 2 | 2005 | 871 | 0.040 |
Why?
|
| Disease Management | 1 | 2008 | 2473 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 6 | 2018 | 2033 | 0.040 |
Why?
|
| Primary Graft Dysfunction | 1 | 2018 | 95 | 0.040 |
Why?
|
| Disease Outbreaks | 2 | 2021 | 1785 | 0.040 |
Why?
|
| Feces | 1 | 2023 | 1419 | 0.040 |
Why?
|
| Paternal Age | 1 | 1997 | 84 | 0.040 |
Why?
|
| Periosteum | 1 | 1998 | 138 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1995 | 1885 | 0.040 |
Why?
|
| Self-Help Groups | 1 | 1999 | 191 | 0.040 |
Why?
|
| General Practitioners | 1 | 2018 | 106 | 0.040 |
Why?
|
| Social Justice | 1 | 2022 | 465 | 0.040 |
Why?
|
| AIDS Serodiagnosis | 2 | 1989 | 187 | 0.040 |
Why?
|
| State Health Plans | 1 | 1999 | 216 | 0.040 |
Why?
|
| Bronchial Diseases | 1 | 1998 | 150 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2001 | 538 | 0.040 |
Why?
|
| Professional Practice | 1 | 1999 | 327 | 0.040 |
Why?
|
| 1-Deoxynojirimycin | 1 | 2016 | 18 | 0.040 |
Why?
|
| Bone Density | 1 | 2010 | 3504 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 414 | 0.040 |
Why?
|
| Pressure | 1 | 2000 | 1207 | 0.040 |
Why?
|
| Cardiovascular System | 1 | 2004 | 834 | 0.040 |
Why?
|
| Test Anxiety Scale | 1 | 2016 | 3 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 1690 | 0.040 |
Why?
|
| Arteries | 2 | 1999 | 1123 | 0.040 |
Why?
|
| Mitotic Index | 1 | 1996 | 172 | 0.040 |
Why?
|
| Psychology, Educational | 1 | 2016 | 6 | 0.040 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1999 | 312 | 0.040 |
Why?
|
| Alcohol Amnestic Disorder | 1 | 1996 | 26 | 0.030 |
Why?
|
| Personality Tests | 3 | 1991 | 83 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2013 | 3941 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2016 | 419 | 0.030 |
Why?
|
| Ethanol | 1 | 2023 | 1346 | 0.030 |
Why?
|
| Empyema, Tuberculous | 1 | 1995 | 2 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2018 | 231 | 0.030 |
Why?
|
| Pneumothorax, Artificial | 1 | 1995 | 5 | 0.030 |
Why?
|
| Immune System | 1 | 2022 | 812 | 0.030 |
Why?
|
| Aspergillosis | 1 | 1998 | 236 | 0.030 |
Why?
|
| Cerebral Decortication | 1 | 1995 | 10 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 3627 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2006 | 2215 | 0.030 |
Why?
|
| Wernicke Encephalopathy | 1 | 1996 | 28 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2000 | 3966 | 0.030 |
Why?
|
| Fatigue | 1 | 2023 | 1536 | 0.030 |
Why?
|
| Quality Control | 1 | 1999 | 839 | 0.030 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 1998 | 824 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2006 | 2761 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1998 | 478 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 2018 | 158 | 0.030 |
Why?
|
| Adoption | 2 | 1993 | 98 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2020 | 560 | 0.030 |
Why?
|
| Contraception Behavior | 1 | 1997 | 188 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 737 | 0.030 |
Why?
|
| Adolescent Psychiatry | 1 | 1997 | 148 | 0.030 |
Why?
|
| Appetite Depressants | 1 | 1996 | 111 | 0.030 |
Why?
|
| Memory | 2 | 2008 | 2188 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2024 | 4723 | 0.030 |
Why?
|
| Standard of Care | 1 | 2019 | 566 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 8199 | 0.030 |
Why?
|
| Small-Area Analysis | 1 | 2015 | 55 | 0.030 |
Why?
|
| Sickness Impact Profile | 2 | 2007 | 308 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2016 | 1859 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2016 | 362 | 0.030 |
Why?
|
| Bone Regeneration | 1 | 1998 | 433 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2010 | 6083 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 395 | 0.030 |
Why?
|
| Stroke | 2 | 2015 | 10152 | 0.030 |
Why?
|
| Diaphragm | 1 | 2016 | 354 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 1795 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 2 | 1992 | 133 | 0.030 |
Why?
|
| Device Removal | 1 | 2020 | 668 | 0.030 |
Why?
|
| Accident Prevention | 1 | 2014 | 78 | 0.030 |
Why?
|
| Drug Industry | 1 | 2001 | 756 | 0.030 |
Why?
|
| Contrast Media | 1 | 2008 | 5338 | 0.030 |
Why?
|
| Cocaine | 2 | 1997 | 996 | 0.030 |
Why?
|
| Taxoids | 2 | 2010 | 671 | 0.030 |
Why?
|
| Child Psychiatry | 1 | 1997 | 220 | 0.030 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2013 | 12 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2021 | 1362 | 0.030 |
Why?
|
| Genome | 1 | 2022 | 1806 | 0.030 |
Why?
|
| Chicago | 5 | 1998 | 241 | 0.030 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2013 | 88 | 0.030 |
Why?
|
| Genomics | 2 | 2020 | 5743 | 0.030 |
Why?
|
| Macrolides | 1 | 1995 | 203 | 0.030 |
Why?
|
| Random Allocation | 4 | 2001 | 2426 | 0.030 |
Why?
|
| Hospitals | 2 | 2021 | 3986 | 0.030 |
Why?
|
| Insurance Claim Review | 2 | 2009 | 724 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2016 | 376 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 11824 | 0.030 |
Why?
|
| Skull | 1 | 1998 | 830 | 0.030 |
Why?
|
| Neoplasm Staging | 4 | 2010 | 11091 | 0.030 |
Why?
|
| Remission Induction | 1 | 2019 | 2386 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 4872 | 0.030 |
Why?
|
| United States Government Agencies | 1 | 2012 | 26 | 0.030 |
Why?
|
| Cattle Diseases | 1 | 1992 | 53 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 673 | 0.030 |
Why?
|
| Sleep Stages | 2 | 2010 | 677 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 2016 | 422 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1621 | 0.030 |
Why?
|
| Computer-Assisted Instruction | 1 | 2015 | 365 | 0.030 |
Why?
|
| Anaplasmosis | 1 | 1992 | 37 | 0.030 |
Why?
|
| Necrosis | 1 | 1996 | 1641 | 0.030 |
Why?
|
| Blood | 1 | 1994 | 593 | 0.030 |
Why?
|
| Tracheostomy | 1 | 1996 | 408 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2023 | 2169 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2013 | 271 | 0.030 |
Why?
|
| Exercise | 1 | 2008 | 5662 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2018 | 1552 | 0.030 |
Why?
|
| Cathartics | 1 | 1993 | 126 | 0.030 |
Why?
|
| Anticoagulants | 2 | 2020 | 4738 | 0.030 |
Why?
|
| Nicotine | 1 | 1997 | 686 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 1992 | 378 | 0.020 |
Why?
|
| Candidiasis, Oral | 1 | 1991 | 59 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1996 | 717 | 0.020 |
Why?
|
| Babesiosis | 1 | 1992 | 92 | 0.020 |
Why?
|
| Hernia | 1 | 1991 | 70 | 0.020 |
Why?
|
| Longevity | 1 | 2019 | 1085 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2001 | 1445 | 0.020 |
Why?
|
| Premenstrual Syndrome | 1 | 1992 | 108 | 0.020 |
Why?
|
| Nerve Net | 1 | 2023 | 2205 | 0.020 |
Why?
|
| Medicare | 2 | 2006 | 6670 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2020 | 3901 | 0.020 |
Why?
|
| Vasectomy | 1 | 1991 | 52 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 2000 | 1354 | 0.020 |
Why?
|
| Iran | 1 | 2014 | 722 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2927 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 2010 | 4794 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1995 | 642 | 0.020 |
Why?
|
| Drug Costs | 3 | 2007 | 1117 | 0.020 |
Why?
|
| Penile Erection | 1 | 1991 | 97 | 0.020 |
Why?
|
| Schizophrenic Psychology | 3 | 1989 | 1673 | 0.020 |
Why?
|
| Health Education | 2 | 2015 | 1064 | 0.020 |
Why?
|
| Sperm Count | 1 | 1991 | 229 | 0.020 |
Why?
|
| Fluorine | 3 | 1985 | 83 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 1168 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2022 | 3131 | 0.020 |
Why?
|
| Family Characteristics | 2 | 1999 | 997 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2018 | 2766 | 0.020 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 1984 | 0.020 |
Why?
|
| Epothilones | 1 | 2010 | 43 | 0.020 |
Why?
|
| Cyclothymic Disorder | 1 | 2010 | 41 | 0.020 |
Why?
|
| Trachea | 1 | 1996 | 1086 | 0.020 |
Why?
|
| Hippocampus | 2 | 2021 | 3713 | 0.020 |
Why?
|
| Sperm Motility | 1 | 1991 | 269 | 0.020 |
Why?
|
| Heroin Dependence | 1 | 1991 | 175 | 0.020 |
Why?
|
| Solubility | 1 | 1992 | 1091 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1995 | 1633 | 0.020 |
Why?
|
| Clinical Competence | 3 | 2015 | 4729 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 1992 | 314 | 0.020 |
Why?
|
| Thoracotomy | 2 | 2004 | 361 | 0.020 |
Why?
|
| Haiti | 1 | 2011 | 552 | 0.020 |
Why?
|
| Accidents | 1 | 2010 | 164 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2000 | 2295 | 0.020 |
Why?
|
| Rescue Work | 1 | 2009 | 56 | 0.020 |
Why?
|
| Heart Failure | 3 | 2020 | 11096 | 0.020 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 1970 | 133 | 0.020 |
Why?
|
| Postoperative Period | 2 | 1991 | 1848 | 0.020 |
Why?
|
| Respiration | 1 | 1996 | 1674 | 0.020 |
Why?
|
| Skin | 1 | 1983 | 4393 | 0.020 |
Why?
|
| Diet, Reducing | 2 | 1991 | 465 | 0.020 |
Why?
|
| Dominance, Cerebral | 3 | 1989 | 626 | 0.020 |
Why?
|
| Economics | 1 | 1989 | 147 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 2005 | 0.020 |
Why?
|
| Absorptiometry, Photon | 2 | 2010 | 1748 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2011 | 734 | 0.020 |
Why?
|
| Radioisotopes | 3 | 1985 | 503 | 0.020 |
Why?
|
| Chiropractic | 2 | 2003 | 39 | 0.020 |
Why?
|
| Massage | 2 | 2003 | 85 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 2553 | 0.020 |
Why?
|
| C-Peptide | 1 | 2010 | 425 | 0.020 |
Why?
|
| Cultural Competency | 1 | 2011 | 294 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 20914 | 0.020 |
Why?
|
| Quinolones | 1 | 1992 | 369 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2010 | 364 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 2675 | 0.020 |
Why?
|
| Allostasis | 1 | 2009 | 71 | 0.020 |
Why?
|
| Child, Orphaned | 1 | 2008 | 55 | 0.020 |
Why?
|
| Alleles | 1 | 2019 | 6954 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3012 | 0.020 |
Why?
|
| Parenting | 1 | 1994 | 695 | 0.020 |
Why?
|
| Cerebral Cortex | 3 | 1984 | 5725 | 0.020 |
Why?
|
| Religion and Psychology | 1 | 1990 | 176 | 0.020 |
Why?
|
| Prosthesis Design | 2 | 1994 | 2127 | 0.020 |
Why?
|
| Antibodies | 2 | 2013 | 2454 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 1996 | 1370 | 0.020 |
Why?
|
| Cerebral Ventricles | 3 | 1986 | 542 | 0.020 |
Why?
|
| Intraoperative Complications | 2 | 1995 | 1206 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2011 | 482 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2000 | 2267 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2010 | 887 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 2010 | 607 | 0.020 |
Why?
|
| Leg | 1 | 1993 | 1123 | 0.020 |
Why?
|
| Relaxation Therapy | 2 | 2003 | 180 | 0.020 |
Why?
|
| Mentally Ill Persons | 1 | 1988 | 126 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 439 | 0.020 |
Why?
|
| Pregnancy | 4 | 2011 | 29630 | 0.020 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2010 | 319 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1991 | 1604 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3717 | 0.020 |
Why?
|
| Angiography | 1 | 1993 | 1640 | 0.020 |
Why?
|
| Choice Behavior | 2 | 2005 | 800 | 0.020 |
Why?
|
| Aggression | 1 | 2012 | 753 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1998 | 1379 | 0.020 |
Why?
|
| Prostheses and Implants | 2 | 1998 | 1390 | 0.020 |
Why?
|
| Urethra | 1 | 1989 | 411 | 0.020 |
Why?
|
| Scotland | 1 | 2006 | 154 | 0.020 |
Why?
|
| Medical Errors | 1 | 2015 | 1296 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5367 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2017 | 2610 | 0.020 |
Why?
|
| Hemorrhoids | 1 | 1986 | 20 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3722 | 0.020 |
Why?
|
| Atrophy | 2 | 1996 | 1600 | 0.020 |
Why?
|
| Cognition Disorders | 2 | 2010 | 4042 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 2 | 1992 | 3561 | 0.020 |
Why?
|
| Collagen | 2 | 1998 | 2689 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2901 | 0.020 |
Why?
|
| Air Pollution, Indoor | 1 | 2013 | 871 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 1522 | 0.020 |
Why?
|
| Barbiturates | 2 | 1976 | 111 | 0.020 |
Why?
|
| Anti-Anxiety Agents | 1 | 2008 | 390 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1992 | 1319 | 0.020 |
Why?
|
| Amphetamines | 2 | 1976 | 148 | 0.020 |
Why?
|
| Glucose | 4 | 1985 | 4396 | 0.020 |
Why?
|
| Wales | 1 | 2005 | 86 | 0.020 |
Why?
|
| Research Personnel | 1 | 2010 | 578 | 0.020 |
Why?
|
| Child Development | 1 | 1997 | 2241 | 0.020 |
Why?
|
| Pleural Diseases | 2 | 1996 | 141 | 0.020 |
Why?
|
| Decision Making | 1 | 1999 | 3909 | 0.020 |
Why?
|
| Policy Making | 2 | 2001 | 552 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2005 | 147 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 1996 | 2611 | 0.020 |
Why?
|
| Truth Disclosure | 1 | 1989 | 440 | 0.020 |
Why?
|
| Rectal Diseases | 1 | 1986 | 142 | 0.020 |
Why?
|
| Urinary Incontinence | 1 | 1989 | 499 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 1184 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2888 | 0.010 |
Why?
|
| Varicose Veins | 1 | 1986 | 156 | 0.010 |
Why?
|
| Observer Variation | 2 | 2006 | 2622 | 0.010 |
Why?
|
| Hypertension, Portal | 1 | 1986 | 220 | 0.010 |
Why?
|
| Temporal Lobe | 2 | 1989 | 1683 | 0.010 |
Why?
|
| Ligation | 1 | 1984 | 455 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1999 | 9305 | 0.010 |
Why?
|
| England | 1 | 2005 | 528 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2005 | 526 | 0.010 |
Why?
|
| Wakefulness | 1 | 2010 | 1246 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2015 | 2033 | 0.010 |
Why?
|
| Politics | 1 | 2010 | 798 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1992 | 1401 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2010 | 2242 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2003 | 184 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1356 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1990 | 1201 | 0.010 |
Why?
|
| Weight Gain | 1 | 1993 | 2317 | 0.010 |
Why?
|
| Software | 1 | 1997 | 4460 | 0.010 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2003 | 266 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2010 | 1160 | 0.010 |
Why?
|
| Evoked Potentials, Visual | 1 | 1984 | 417 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1991 | 2275 | 0.010 |
Why?
|
| Systole | 1 | 2004 | 960 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7400 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2005 | 936 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2017 | 6567 | 0.010 |
Why?
|
| Life Style | 4 | 2004 | 3861 | 0.010 |
Why?
|
| History, Modern 1601- | 1 | 1981 | 16 | 0.010 |
Why?
|
| Body Weight | 2 | 1991 | 4703 | 0.010 |
Why?
|
| Informed Consent | 1 | 1988 | 1000 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 1989 | 1508 | 0.010 |
Why?
|
| Hemodilution | 2 | 1992 | 113 | 0.010 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1984 | 517 | 0.010 |
Why?
|
| Vaccination | 1 | 2013 | 3354 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2000 | 5751 | 0.010 |
Why?
|
| Hyperalgesia | 1 | 2005 | 503 | 0.010 |
Why?
|
| Tourette Syndrome | 1 | 1984 | 389 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 776 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2013 | 3487 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2010 | 2264 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 2001 | 206 | 0.010 |
Why?
|
| Endoscopy | 1 | 2010 | 1839 | 0.010 |
Why?
|
| Veins | 1 | 1984 | 771 | 0.010 |
Why?
|
| Receptors, Serotonin | 1 | 2001 | 202 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 640 | 0.010 |
Why?
|
| Cost Allocation | 1 | 1999 | 51 | 0.010 |
Why?
|
| New York | 3 | 1977 | 885 | 0.010 |
Why?
|
| Direct Service Costs | 1 | 1999 | 60 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2003 | 571 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3511 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2005 | 2043 | 0.010 |
Why?
|
| Preoperative Care | 3 | 1995 | 2258 | 0.010 |
Why?
|
| Nociceptors | 1 | 1983 | 436 | 0.010 |
Why?
|
| Maximal Voluntary Ventilation | 1 | 1998 | 13 | 0.010 |
Why?
|
| Insulin | 1 | 2013 | 6623 | 0.010 |
Why?
|
| Electroencephalography | 2 | 1984 | 6117 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 2088 | 0.010 |
Why?
|
| Implosive Therapy | 1 | 2000 | 119 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1986 | 1144 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1991 | 4403 | 0.010 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 1998 | 40 | 0.010 |
Why?
|
| Life Tables | 1 | 1998 | 371 | 0.010 |
Why?
|
| Carboplatin | 1 | 2001 | 802 | 0.010 |
Why?
|
| Animals | 5 | 1999 | 169600 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 2090 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2006 | 7970 | 0.010 |
Why?
|
| Thoracostomy | 1 | 1998 | 72 | 0.010 |
Why?
|
| Point-of-Care Systems | 1 | 2006 | 1184 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4598 | 0.010 |
Why?
|
| Antimetabolites | 1 | 1998 | 125 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2003 | 880 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1998 | 322 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1983 | 1756 | 0.010 |
Why?
|
| Intraoperative Care | 2 | 1992 | 764 | 0.010 |
Why?
|
| Osteocalcin | 1 | 1998 | 273 | 0.010 |
Why?
|
| Adenocarcinoma | 2 | 2010 | 6387 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2010 | 3889 | 0.010 |
Why?
|
| Opium | 1 | 1976 | 29 | 0.010 |
Why?
|
| Pleura | 1 | 1998 | 244 | 0.010 |
Why?
|
| Calcitriol | 1 | 1998 | 296 | 0.010 |
Why?
|
| Polyglycolic Acid | 1 | 1998 | 408 | 0.010 |
Why?
|
| Condoms | 1 | 1998 | 322 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2011 | 3808 | 0.010 |
Why?
|
| Empyema, Pleural | 1 | 1996 | 62 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2010 | 6458 | 0.010 |
Why?
|
| Bronchial Fistula | 1 | 1996 | 85 | 0.010 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 1976 | 46 | 0.010 |
Why?
|
| Osteocytes | 1 | 1998 | 199 | 0.010 |
Why?
|
| Diastole | 1 | 1998 | 792 | 0.010 |
Why?
|
| Thoracoplasty | 1 | 1995 | 15 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1998 | 850 | 0.010 |
Why?
|
| Biotechnology | 1 | 1998 | 280 | 0.010 |
Why?
|
| Psychology, Social | 1 | 1995 | 51 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1998 | 424 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1998 | 694 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 1997 | 456 | 0.010 |
Why?
|
| Surgical Mesh | 1 | 1998 | 280 | 0.010 |
Why?
|
| Heroin | 1 | 1976 | 116 | 0.010 |
Why?
|
| Blood-Borne Pathogens | 1 | 1994 | 52 | 0.010 |
Why?
|
| Culture | 1 | 1979 | 636 | 0.010 |
Why?
|
| Fistula | 1 | 1996 | 221 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 1998 | 412 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2010 | 3480 | 0.010 |
Why?
|
| Caudate Nucleus | 2 | 1986 | 394 | 0.010 |
Why?
|
| Social Behavior | 1 | 2001 | 1132 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 11909 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1989 | 4185 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 2499 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 2715 | 0.010 |
Why?
|
| Rest | 1 | 1998 | 915 | 0.010 |
Why?
|
| Jurisprudence | 1 | 1993 | 111 | 0.010 |
Why?
|
| Anaplasma | 1 | 1992 | 5 | 0.010 |
Why?
|
| Constriction | 1 | 1993 | 180 | 0.010 |
Why?
|
| Arachnid Vectors | 1 | 1992 | 25 | 0.010 |
Why?
|
| West Indies | 1 | 1992 | 34 | 0.010 |
Why?
|
| HIV Infections | 2 | 2010 | 16882 | 0.010 |
Why?
|
| Pulmonary Emphysema | 1 | 1998 | 679 | 0.010 |
Why?
|
| Episode of Care | 1 | 1993 | 126 | 0.010 |
Why?
|
| Heart Rate | 1 | 2004 | 4108 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 1996 | 546 | 0.010 |
Why?
|
| Chondrocytes | 1 | 1998 | 804 | 0.010 |
Why?
|
| Babesia | 1 | 1992 | 28 | 0.010 |
Why?
|
| Neurotic Disorders | 1 | 1992 | 79 | 0.010 |
Why?
|
| Bloodletting | 1 | 1992 | 23 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2001 | 1611 | 0.010 |
Why?
|
| Osteoblasts | 1 | 1998 | 1163 | 0.010 |
Why?
|
| Insect Vectors | 1 | 1992 | 135 | 0.010 |
Why?
|
| Drug Utilization | 1 | 1998 | 1180 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1995 | 13678 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 1998 | 1402 | 0.010 |
Why?
|
| Hyperemia | 1 | 1993 | 226 | 0.010 |
Why?
|
| Pediatrics | 1 | 1986 | 3517 | 0.010 |
Why?
|
| Rabbits | 1 | 1998 | 4910 | 0.010 |
Why?
|
| Temperament | 1 | 1993 | 282 | 0.010 |
Why?
|
| Home Care Services | 1 | 1997 | 622 | 0.010 |
Why?
|
| Hematocrit | 1 | 1992 | 636 | 0.010 |
Why?
|
| Germany, West | 1 | 1970 | 13 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 2000 | 1606 | 0.010 |
Why?
|
| Complement Fixation Tests | 1 | 1970 | 78 | 0.010 |
Why?
|
| Energy Metabolism | 2 | 1996 | 2908 | 0.010 |
Why?
|
| Legislation as Topic | 1 | 1990 | 80 | 0.010 |
Why?
|
| Disease Reservoirs | 1 | 1970 | 131 | 0.010 |
Why?
|
| Genes | 1 | 1993 | 1885 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 1977 | 1087 | 0.010 |
Why?
|
| Catheterization, Peripheral | 1 | 1993 | 347 | 0.010 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 1970 | 168 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1992 | 874 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1994 | 1213 | 0.010 |
Why?
|
| Problem Solving | 1 | 1991 | 440 | 0.010 |
Why?
|
| Zoonoses | 1 | 1970 | 187 | 0.010 |
Why?
|
| Acupuncture Therapy | 1 | 1993 | 464 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1995 | 2893 | 0.000 |
Why?
|
| Neutralization Tests | 1 | 1970 | 760 | 0.000 |
Why?
|
| Mice | 2 | 1992 | 81766 | 0.000 |
Why?
|
| Urodynamics | 1 | 1989 | 348 | 0.000 |
Why?
|
| Catheterization | 1 | 1993 | 1467 | 0.000 |
Why?
|
| Body Image | 1 | 1991 | 627 | 0.000 |
Why?
|
| Portography | 1 | 1986 | 12 | 0.000 |
Why?
|
| Cattle | 1 | 1992 | 3926 | 0.000 |
Why?
|
| Patient Education as Topic | 1 | 1996 | 2297 | 0.000 |
Why?
|
| Critical Care | 1 | 1998 | 2696 | 0.000 |
Why?
|
| Putamen | 1 | 1986 | 290 | 0.000 |
Why?
|
| Globus Pallidus | 1 | 1986 | 252 | 0.000 |
Why?
|
| Stem Cells | 1 | 1998 | 3581 | 0.000 |
Why?
|
| Length of Stay | 1 | 1998 | 6355 | 0.000 |
Why?
|
| Occipital Lobe | 1 | 1986 | 376 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 2000 | 4280 | 0.000 |
Why?
|
| Ischemia | 1 | 1993 | 1924 | 0.000 |
Why?
|
| Delta Rhythm | 1 | 1984 | 78 | 0.000 |
Why?
|
| Alpha Rhythm | 1 | 1984 | 111 | 0.000 |
Why?
|
| Gene Frequency | 1 | 1990 | 3591 | 0.000 |
Why?
|
| Urinary Bladder | 1 | 1989 | 1181 | 0.000 |
Why?
|
| Communication | 1 | 1996 | 3815 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1998 | 19270 | 0.000 |
Why?
|
| Preventive Health Services | 1 | 1986 | 576 | 0.000 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1986 | 740 | 0.000 |
Why?
|
| Education, Medical, Continuing | 1 | 1986 | 844 | 0.000 |
Why?
|
| Mesencephalon | 1 | 1982 | 330 | 0.000 |
Why?
|
| Aspirin | 1 | 1992 | 3332 | 0.000 |
Why?
|
| Thalamus | 1 | 1986 | 1032 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1995 | 4062 | 0.000 |
Why?
|
| Rural Population | 1 | 1970 | 2245 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 18174 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2000 | 11211 | 0.000 |
Why?
|
| Socialization | 1 | 1977 | 87 | 0.000 |
Why?
|
| Juvenile Delinquency | 1 | 1977 | 123 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1982 | 2748 | 0.000 |
Why?
|